Iron depletion before HCV antiviral therapy: a pilot, randomized, controlled trial.

@article{Gentile2009IronDB,
  title={Iron depletion before HCV antiviral therapy: a pilot, randomized, controlled trial.},
  author={Ivan Gentile and Chiara Viola and Luigi Paesano and Marcello D'Onofrio and Elio D'Agostino and Raimondo Cerini and Francesco Borrelli and Marcello Piazza and Guglielmo Borgia},
  journal={Journal of clinical apheresis},
  year={2009},
  volume={24 5},
  pages={190-6}
}
It is not known whether iron depletion before pegylated IFN or combination treatment improves sustained virological response (SVR) rate in patients with chronic hepatitis C, despite its use in clinical practice in this setting. We aimed to investigate whether blood letting improves the efficacy (SVR) and tolerability of PEG-IFNalpha2b + Ribavirin in chronic hepatitis C patients. Patients with chronic hepatitis C and ferritin >100 ng/mL were randomized to: (1) repeated phlebotomies to obtain a… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 17 extracted citations

Hepatitis C, porphyria cutanea tarda and liver iron: an update.

Liver international : official journal of the International Association for the Study of the Liver • 2012
View 9 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…